Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness - Scorecard - MDSpire

Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness

  • By

  • Pedro D. Wendel-Garcia

  • Sebastian Morales

  • Paulo Melo

  • Greta Emilia Kiavialaitis

  • Peter Wohlrab

  • Ricardo Castro

  • Edda Tschernko

  • Glenn Hernández

  • Eduardo Kattan

  • April 14, 2026

  • 0 min

Share

Clinical Scorecard: Norepinephrine Dosing Adjusted for Weight and Vasopressin Responsiveness in Relation to Body Mass Index

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationObese patients with septic shock requiring vasopressor support
Care Setting

Key Highlights

  • Clarify the implications of absolute dosing metrics on clinical practice.

Guideline-Based Recommendations

Diagnosis

    Management

    • Evaluate NE dosing based on absolute units rather than weight-normalized metrics.
    • Consider alternative adjunctive strategies if true AVP resistance is confirmed.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Include criteria for confirming AVP resistance.

        Clinical Best Practices

        • Utilize absolute dosing metrics for NE to avoid scaling artifacts.
        • Assess hemodynamic response over longer observation periods using specific metrics.
        • Re-evaluate clinical decision-making thresholds based on accurate severity assessments.

        References

        Original Source(s)

        Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness

        • by Pedro D. Wendel-Garcia, Sebastian Morales, Paulo Melo, Greta Emilia Kiavialaitis, Peter Wohlrab, Ricardo Castro, Edda Tschernko, Glenn Hernández, Eduardo Kattan

        • April 14, 2026

        Related Content

        Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches

        AD Not Linked to Early CV Risk Markers

        Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

        Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study